Topics

Purdue Pharma Announces Landmark Agreement with Oklahoma to Advance the Treatment of Addiction

14:43 EDT 26 Mar 2019 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
Settlement will establish national center for addiction studies and treatment in Tulsa; Sackler family announces voluntary contribution to support national center Purdue Pharma L.P. today announced that it has ente...

Other Sources for this Article

Media:
Robert Josephson
Purdue Pharma L.P.
Office: +1-203-588-7114
Robert.Josephson@pharma.com

NEXT ARTICLE

More From BioPortfolio on "Purdue Pharma Announces Landmark Agreement with Oklahoma to Advance the Treatment of Addiction"

Quick Search

Relevant Topics

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Psychiatry
Psychiatry is the study of mental disorders and their diagnosis, management and prevention.  Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...